The scandal, which came to light in March last year, involved the illegal and improper storage, transport and sale of tens of millions of dollars' worth of vaccines - many of them expired.
The Jinan Intermediate People's Court sentenced Pang Hongwei, one of the key players in the scheme, to 19 years in prison for illegal business practices, according to a statement posted Tuesday on its verified Weibo social media account.
Between June 2013 and April 2015, Pang bought and improperly stored rabies, flu, and hepatitis B vaccines and sold them around the country, sales of which amounted to nearly 75 million yuan (USD 11 million), according to the court.
Sun helped in accounting, receiving and sending vaccines, and making bank transfers from September 2014 to April 2015, the court said.
Although the two suspects were arrested in April 2015, the vaccine scandal was not publicised until nearly a year later, arousing public fury over authorities' delay.
The sentence followed two cases in December and January where a former Chinese official and his wife were both jailed for taking bribes from vaccine manufacturers to gain approval for their drugs.
Standard vaccines such as those for polio, hepatitis B and measles are mandatory for all children in China and supplied by the state, while parents can opt to buy additional immunisations privately such as those for meningitis, influenza or rotavirus.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
